JPMDL Denies Request To Centralize Cases Alleging Benzene In Acne Products
WASHINGTON, D.C. — The U.S. Judicial Panel on Multidistrict Litigation (JPMDL) on Aug. 1 declined to centralize cases that allege that users of benzoyl peroxide XE "benzoyl peroxide" (BPO) products for...To view the full article, register now.
Already a subscriber? Click here to view full article